Abstract:The vast majority of measurable phenotypes within species are not fixed, and populations contain significant levels of natural genetic variation among individuals affecting phenotypes from development to metabolism to abiotic resistance. All of these phenotypes are of interest to both basic and applied biologists from a myriad of fields. Despite the ubiquity of this variation, little is known about the molecular underpinnings of natural genetic variation or the forces behind its maintenance or generation. Recent advances in both genomics and systems biology are beginning to allow some of the first direct empirical tests of a suite of parameters that while being a foundation of natural variation were largely left to the theoreticians. These include the following basic questions: What is pleiotropy? How many genes control a given quantitative trait? Where is the heritability? How is conditional genetic variation generated? This review highlights progress made toward addressing these questions via the use of systems biological inquiries into natural variation. The vast majority of measurable phenotypes within species are not fixed, and populations contain significant levels of natural genetic variation among individuals for traits ranging from development to metabolism to abiotic resistance. While the presence of this diversity is widely acknowledged, much less is known about the consequences of natural genetic variation or the forces behind its maintenance or generation, which are fundamental to evolution and ecology. In addition, a wide range of applied fields is finding a need to better understand the systematic basis of natural variation, including efforts to improve crop yields via breeding and attempts toward individualized medicine for humans. These efforts are complicated because this diversity is typically polygenic and can involve complex interactions with numerous factors, including, but not limited to, the environment, development, epistatic interactions between genes, and potential higher-order interaction among these factors (Falconer and Mackay, 1996; Lynch and Walsh, 1998; Wentzell and Kliebenstein, 2008). While most studies on natural variation to date have queried one or two phenotypes, there is an obvious need for more intricate, genomic, and broad phenotypic analyses of natural variation to address the fundamentals of quantitative genetics. Systems biology is a newly defined and emerging field that attempts to conduct massively parallel experiments that differentially perturb a system to identify the properties of the system being tested (Ideker et al., 2001; Kitano, 2002). This has led to the systematic identification of networks controlling gene expression within bacteria and protein interactions in numerous species and metabolic networks (Fiehn, 2002; Rosenfeld et al., 2002; Covert et al., 2004; Martins et al., 2004). The utility of systems biology has gone beyond the ability to describe individual phenotypes to begin describing the shape of the mechanistic interactions or rules that define how the networks can be shaped (Albert, 2005). Systems biology has also begun to make great headway in helping to better understand and describe plant biology (Brady and Provart, 2009). This includes the development of key approaches to combine metabolomic and transcript data to identify novel enzymatic and regulatory genes (Hirai et al., 2005; Hansen et al., 2007). This approach has further been extended to establish links between gene expression and root development and between development and abiotic stress within Arabidopsis (Arabidopsis thaliana; Brady et al., 2007; Dinneny et al., 2008). As such, the concept and implementation of systems biology is showing great promise to establish both individual gene linkages and more theoretical rules guiding these linkages. Numerous systems biology approaches are now being applied to the study of natural genetic variation, including transcriptomics (Keurentjes et al., 2008; Kliebenstein, 2009c), metabolomics (Keurentjes, 2009; Kliebenstein, 2009a), proteomics (Stylianou et al., 2008), compilation of large physiological data sets (Keurentjes et al., 2008), network analysis tools (Hansen et al., 2008; Kliebenstein, 2009b), and whole-genome sequencing (Borevitz and Chory, 2004; Nordborg and Weigel, 2008). Each of these approaches has a myriad of strengths and aid in the rapid identification of the genes underlying phenotypes ranging from flowering time to biotic resistance mechanisms. However, their potential uses in understanding the genetic underpinnings of specific biological phenotypes have been reviewed extensively in the past several years as described in the preceding citations. Given the depth of published reviews on the use of systems biology to 1 This work was supported by the National Science Foundation (grant no. DBI 0820580 to D.J.K.). * E-mail kliebenstein@ucdavis.edu. The author responsible for distribution of materials integral to the findings presented in this article in accordance with the policy described in the Instructions for Authors (www.plantphysiol.org) is: Daniel J. Kliebenstein (kliebenstein@ucdavis.edu). www.plantphysiol.org/cgi/doi/10.1104/pp.109.149328

[Study on the content of imperatorin and HPLC fingerprint of Baizhi collected from different areas].

Mesenchymal Stem Cell-Based Immunomodulation: Properties and Clinical Application

Semiautomated pH gradient ion-exchange chromatography of monoclonal antibody charge variants.

Immunomodulatory Mechanisms of Mesenchymal Stem Cells and Their Potential Clinical Applications

Enhancing Mesenchymal Stromal Cell Immunomodulation for Treating Conditions Influenced by the Immune System

Mesenchymal stem/stromal cells as a valuable source for the treatment of immune-mediated disorders

An improved simple polarisable water model for use in biomolecular simulation.

Current understanding of the immunosuppressive properties of mesenchymal stromal cells

Effects of living and metabolically inactive mesenchymal stromal cells and their derivatives on monocytes and macrophages

Mesenchymal Stromal Cells Affect Disease Outcomes Via Macrophage Polarization

Menstrual Blood-Derived Stem Cells: Toward Therapeutic Mechanisms, Novel Strategies, and Future Perspectives in the Treatment of Diseases

MSCs and Inflammatory Cells Crosstalk in Regenerative Medicine: Concerted Actions for Optimized Resolution Driven by Energy Metabolism

Identifying the Therapeutic Significance of Mesenchymal Stem Cells

Marine natural products: Bryostatins in preclinical and clinical studies

Use of priming strategies to advance the clinical application of mesenchymal stromal/stem cell-based therapy

Human mesenchymal stem cells: From immunophenotyping by flow cytometry to clinical applications

HOXgene clusters are hotspots of de novomethylation in CpG islands of human lung adenocarcinomas

The secretion profile of mesenchymal stem cells and potential applications in treating human diseases

Update on Systems Biology and Natural Genetic Variation Systems Biology Uncovers the Foundation of Natural Genetic Diversity 1

Purification and electrophoretic characterization of bovine conglutinin.

Functional enhancement strategies for immunomodulation of mesenchymal stem cells and their therapeutic application